38 results
8-K
EX-1.1
VBIVQ
VBI Vaccines Inc
15 May 24
VBI Vaccines Reports First Quarter 2024 Financial Results
4:18pm
laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or hazardous substances
8-K
EX-10.1
VBIVQ
VBI Vaccines Inc
11 Apr 24
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:07pm
, pollutants, contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment, or otherwise relating
8-K
EX-1.1
7fe7u7mp2 v9
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-1.1
3frqy8
3 Sep 21
Entry into a Material Definitive Agreement
8:53am
S-3ASR
EX-1.2
knzug8mtg7n5a9mdkg
31 Jul 20
Automatic shelf registration
4:58pm
8-K
EX-1.1
mi6aapu
24 Apr 20
VBI Vaccines Announces Proposed Public Offering of Common Shares
6:16am
8-K
EX-1.1
vqob31yo53m yu8v062
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
8-K
EX-1.1
wiespa xyqbzfeyvd
17 Dec 18
VBI Vaccines Announces Proposed Public Offering of Common Shares
12:00am
10-K
i1ei x3bg
20 Mar 17
Annual report
12:00am
424B3
rc6jtc4ztts zn83shm0
8 Apr 16
Prospectus supplement
12:00am